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ABSTRACT 
Background: Our aim was to evaluate the neurocognitive performance in adolescents 
with CHD and to determine whether parameters of fetal development evaluated in 
neonates, such as head circumference, length, weight and Apgar scores, are somehow 
related to their neurocognitive performance. 
Methods: We evaluated 77 CHD patients (43 males) aged from 13 to 18 years old 
(mean=15.04 ± 1.86), 46 cyanotic (23 Tetralogy of Fallot, 23 Transposition of the Great 
Arteries) and 31 acyanotic (Ventricular Septal Defect) enrolled in this study. The 
control group included 16 healthy children (11 males) ages ranging from 13 and 18 
(mean=15.69 ± 1.44). All assessment measures for CHD patients were once obtained in 
a tertiary hospital; the control group was evaluated in school. Neuropsychological 
assessment included Wechsler’s Digit Test, direct and reverse (WDD, WDR) and 
Symbol Search (WSS), Rey’s Complex Figure (RCF), BADS’s Key Searching Test 
(BKS), Color-Word Stroop Test (CWS), Trail Making Test (TMT) and Logical 
Memory Task (LMT). 
Results: CHD patients compared to control group showed lower scores on every test, 
except for a logical memory task. Patients with VSD when compared with patients with 
TF and TGA showed better results in all neuropsychological tests, although the only 
significant differences were in evidence RCF, copy (F=4,936; p=.010). Several 
correlations were apparent between fetal/ neonatal parameters and neuropsychological 
abilities in each type of CHD. However, head circumference at birth stands as a main 
correlation with cognitive development later on in all kinds of CHD (WDD: rho=.339, 
p=.011; RCF, copy: rho=.297, p=.027; CWS, interference: rho=.283, p=.036; TMT A: 
rho=-.321, p=.017).  
Conclusions: Adolescents with CHD have worse neuropsychological performance than 
the control group, mainly the cyanotic patients. Fetal circulation seems to have impact 
on cerebral and somatic growth, predicting cognitive impairment in adolescents with 
CHD. 
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INTRODUCTION 
Congenital heart disease has been considered as the most common cause of child 
morbidity and mortality.
1 
In recent decades, the advances in surgical interventions and treatment in patients 
with CHD, have contributed to the increase of life expectancy of these children. 
However, over half of these children will develop some kind of neurological 
damage.
2,3,4 
In the literature, different studies refer to the existence of changes in cognitive 
development of young people with congenital heart disease. These consequences are 




Many children that were submitted to cardiac surgery in the neonatal period, show a 
pattern of neurological problems throughout their development, such as, cognitive 
deficits, attention problems and executive functioning, visual-motor e visual-spatial 




Until today, studies about neurological development in children with congenital heart 
disease have only been focused on factors related to surgeries, such as cerebral 
perfusion being compromised during extra corporal circulation
1 
and these factors were 
considered precursors of potential complications neurocognitive.
14 
Despite this, other 
studies have found a high percentage of neurological abnormalities, anatomical and 
functional, before surgery in newborn babies with congenital heart disease
15,16,17 
and 
also found a connection between these abnormalities and cognitive development 
throughout childhood.  
According to some studies, neurobehavioral abnormalities, such as hypotonic, 
agitation, motor asymmetry, lethargy and autistic characteristics,  were found prior to 
surgery in over 50% of newborns (less than a month old) and 38% of children (between 
one month old and 2 years old) with congenital heart disease. These abnormalities 
usually persist or get worse in the postoperative period, when cranial nerve damage may 
also occur.
18,19 
Still during the postoperative period, other complications may also occur, being the 
most common ones characterized as agenesis or dysgenesis of corpus callosum, 
holoprosencephaly, microcephaly, lissencephaly,
20
 incomplete closure of the 




Newborns with congenital heart disease show higher risk of developing hypoxia, 
hypotension and acidosis.  
The fetal hypoxia affects the normal development of the brain, namely in the 
hippocampus (a brain structure responsible for converting short-term memory into long 
term memory) and the cerebral cortex (the brain structure responsible for cognitive 
areas related to memory, attention , language, perception and thought).
22
 This may due 




Other hypothesis suggest that abnormalities in cerebral development,  inter-uterus 
hemodynamic alterations and congenital cerebral abnormalities and acquired cerebral 
lesions, linked to prolonged cyanosis and hypoperfusion after birth,
1 
also contribute to 
the neurological development difficulties in children with congenital heart disease.
15 
Newborns with congenital heart disease show high levels of acquired cerebral 
lesions, proved by studies using postoperative magnetic resonance imaging scans. The 
high number of cases of newborns with lesions in the white substance suggests that 
there is a vulnerability that might be related with the delay in brain development. These 
abnormalities in newborns with congenital heart disease may reflect trouble in cerebral 
blood flow in the fetus.
24 
 For many newborns, congenital heart disease seems to be an isolated anomaly, 
leading to the belief that the brain has potential for a normal development.
25
 Although 
brain and heart development occur simultaneously in the fetus with congenital heart 
disease, being the first morphogenetic programs of each organs share the same genetic 
pathways.  
 In the seventh week of the gestation period the heart is considered to be 
morphologically mature, but brain development will continue on, as different 
morphological events occur throughout the first two trimesters,
24
 such as neuronal 
migration and arborization, synaptogenesis, programmed  cellular death, 
oligodendrocytes maturation and reorganization or synaptic connections.
15 
 Following this period, there is a constant brain growth and it is directly linked with 
the formation and perfectioning of connections in the third trimester and neonatal 
period.
24 
This development is associated with the increase in metabolic activity in which 
the brain relies on the heart for oxygen and nutrient supply.  
 The existence of congenital heart disease will increase the chances of blood flow 
abnormalities in the fetus, resulting in a compromised brain development due to the 
complex relations between common cells, genetic programming, physiological 
consequences of cerebral blood flow alterations and the dynamic of oxygen distribution 
during brain development.
24 
This can be seen as good evidence that these factors take an 
important role in cerebral growth.
26 
 In what is considered as normal fetal circulation, gas exchange occurs through the 
placenta. The deoxygenized blood coming from the vena cava goes directly in the right 
ventricle and through the arterial canal to the placenta. The Eustachian valve and the 
arterial septum move together to get the venous blood from the hepatic inferior vena 
cava to the right ventricle and the oxygenated blood from the venous canal over the oval 
foramen through the left ventricle to the aorta and cerebral circulation.        
 When the fetal oxygenation is compromised there is a blood redistribution to the 
cerebral circulation, this phenomenon is known as brain sparing,
1
 resulting in a pattern 
of global distribution of the somatic growth, with preservation of the head growth.
24 
This hemodynamic growth is represented by the diastolic flow in the cerebral arteries 
and the decrease of diastolic flow in the descending and umbilical aorta.
1 
It is believed 
that many brain areas may be better protected than others. According to Dubiel, 
Gunnarsson & Gunnarsson
27
, a study with pregnant women with complications in their 
pregnancy due to maternal hypertension and placenta dysfunction, cerebral 
vasodilatation was found in 41% of women in the anterior cerebral artery, 30% in the 
posterior cerebral artery and 24% in the medium cerebral artery. In this way, anterior 
cerebral arteries show a better auto regulative response, were the redistribution of blood 
flow is favorable to the perfusion of the frontal lobes. Although, medium cerebral 
arteries are presented as less reactive.
1 
  This mechanism has been found to be a contributor to an adverse neurological 
development, since the cerebral vasodilatation occurs when there is a compromise in the 
fetal oxygenation. This protection mechanism doesn’t seem to be enough to keep a 
normal brain development and growth in prolonged stress situations in the uterus.
 
In a 
normal fetal blood circulation, the oxygenated blood is taken to the brain and the 
deoxygenized blood goes to the placenta.
1 
As previously said, studies show abnormalities in blood flow, that occur in 
congenital heart disease, such as Hypoplasic Left Heart Syndrome, Transposition of the 




In fetus with Hypoplasic Left Heart Syndrome there may be an increase in the 
resistance to cerebral flow, where the blood flow returns through an istmo-aortic 
hypoplasic in order to get to the brain.  
In fetus with Transposition of the Great Arteries, the venous blood from the cerebral 
circulation goes back directly to the brain. 
When Tetralogy of Fallot and Hypoplasic Right Heart Syndrome, is found in fetus, 
the deoxygenized blood goes in the cerebral circulation due to the intracardiac mix.  
This allows the statement that the type of injury does not only affect the cerebral 
blood flow but also the degree of deoxygenized blood distributed in the cerebral 
circulation. 
1 
All alterations in the blood flow may be related to some sort of abnormal somatic 




When comparing to newborns without congenital heart disease, newborns with 
Hypoplasic Left Heart Syndrome show lower weight, length and head circumference 
smaller than normal and the head volume is disproportionally low when compared to 
their weight. Newborns with Transposition of the Great Arteries show normal weight, 
but a lower head circumference when compared to their weight. These statements are 
corroborated by Rivkin and collaborators, who reported that adolescents with TGA 
undergoing surgery type "pressure switch" in the first months of life, have abnormalities 
of the white substance, namely the reduction of the same.
28
 On the other hand, 
newborns with Tetralogy of Fallot have normal proportions, although their weight, 
length and head circumference are smaller than expected. Children with Coarctation of 
the Aorta have higher head volume, when compared to their weight at birth.
1, 23, 24,29
 
Many factors are believed to be related to the low weight at birth, including genetic 
syndromes, placenta insufficiency, and inter-uterine growth restriction. All these may 
increase the risk of neurodevelopment delays.  
Recently, Gaynor, Jarvik, Bernbaum, Gerdes, Wernovsky et al
30 
showed that, in 
general, factors inherent to the patient, such as weight at birth, head circumference at 
birth and the Apgar score in the first and fifth minute, better explain the vulnerability of 
mental and psychomotor growth than the intraoperative factors (weight in surgery, 
cooling time, deep hypothermic circulatory arrest time, cardiopulmonary bypass time, 
lowest nasopharyngeal temperature).  
 
 
Patients and Methods 
The sample consists of 93 participants, between 13 and 18 years of age, divided in 
two groups: a congenital heart disease group (CHD), composed of 77 patients recruited 
from the outpatient pediatric cardiology clinic at the Hospital de Sao Joao (Porto); and a 
group control (CG), made up of 16 adolescents from several schools in the Porto city 
area (Table 1). The CHD group is further divided in three groups corresponding to 
different types of congenital heart disease: Transposition of the Great Arteries (TGA) 
(n=23); Tetralogy of Fallot (TF) (n= 23); Ventricular Septal Defect (VSD) (n= 31). 
Tables 1 and 2 display the characteristics of the sample. 
Control group and CHD group do not differ according to age (p=.197),  gender (χ2= 
.906; p=.412) and years of education (p=.055). The same is valid for the three 
subgroups of CHD regarding age (H=.420; p=.811), gender (χ2= 3,195; p=.202) and 




In order to collect all necessary information for this study, all participants underwent 
a brief neuropsychological assessment, designed to evaluate a number of neurocognitive 
functions over a short period of time.   
Different tests were used for this purpose such as, Wechsler's Digit Test, in direct 
and indirect form, focused on the assessment of immediate auditory-verbal attention and 
working memory, respectively; Wechsler's Symbol Search, used to evaluate 
psychomotor performance, speed of execution, perceptive organization and persistence. 
Rey’s Complex figure, copy and reproduction from memory three minutes after image 
exposure, was used in order to assess visual constructional ability and visual 
constructional memory. The Key Search Test, from the Behavioral Assessment of the 
Dysexecutive Syndrome- children, focuses on the evaluation of the capability for 
efficient planning.  
Color-word Stroop Test was used to assess attention efficiency. Trail Making Test, 
part A focuses on the evaluation of visual spatial orientation, psychomotor speed, while 
part B is to assess divided attention.  







Statistical analysis was carried out using the program IBM SPSS Statistics for 
Windows, version 21. A comparison of the obtained results on the neuropsychological 
tests between the control and CHD group and also between the CHD subgroups  was 
made through the U of Mann-Whitney. The Spearman correlations were used in order to 
correlate neonatal variables (weight, length, cephalic perimeter and APGAR indexes) 
with the results obtained by the CHD group and subgroups. Finally, a regression analyse 
was conducted to determine the relationship between the independent variables (head 
circumference and cyanosis) and the indice of total cognitive performance. Significance 
was determined with p≤0.05. 
 
Results 
Relatively to the performance of the Control and CHD groups, in the 
neuropsychological tests, it can be verified through the Table 3 the significant 
differences in the neurocognitive performance between the groups, with better resulted 
in the performance of the CG, with exception of the task Logical Memory.
 
The table 4 represents the comparison of the results obtained in the 
neuropsychological tests by the subgroups of CHD (VSD, TF and TGA). Thus, we see 
that the VSD subgroup show better results compared to the cyanotic subgroups (TF and 
TGA), presenting only as statistically significant differences in RCFm (p =.010).
 
In order to verify the existence of a significant correlation between indices of fetal 
brain development and neonatal parameters and cognitive performance in 
neuropsychological tests administered in the total sample and in the group and 
subgroups of CHD, we used the Spearman correlation (rho), since the distribution of the 
sample is not homogeneous. 
 
With regard to table 5 analysis verifies that, the CHD group, indices of fetal brain 
development correlates positively and significant statistically with the 
neuropsychological tasks: head circumference with WDD (rho=.339; p=.011), RCFc 
(rho=.297; p=.027) and StroopI (rho=.283; p=.036); weight with RCFc (rho=.254; 
p=.035) and BKS (rho=.340; p=.004). Even in this group, the head circumference 
variable correlates negative and significant statistically with the TMT A (rho=-.321; 
p=.017).
According to table 6, it turns out that in VSD group, the indices of fetal brain 
development correlates positive and significant statistically with neuropsychological 
tasks: head circumference with BKS (rho=.463; p=.017), length with StroopW 
(rho=.428; p=.023) and weight with BKS (rho=.518; p=.004). 
In the table 7 it is possible to verify that, in TF subgroup, the neonatal variable Apgar 
indice (2) correlates positive and significant statistically with StroopW (rho=.523; 
p=.031) and StroopC (rho=.559; p=.020). The weight  variable correlates positive and 
significant statistically with RCFc (rho=.458; p=.037).  
 
Table 8 shows that, in TGA subgroup, the Apgar indice (1) correlates positive and 
significant statistically with TMT-B (rho=.565; p=.018) while the Apgar indice (2) 
correlates positive and significant statistically with TMT-B (rho=.584; p=.015).  
Even in this group, the Apgar indice (2) correlates positive and significant 
statistically with WDI (rho=-.506; p=.038) and WSS (rho=-.502; p=.040). 
Finally, as we conducted the regression analyses we could confirm some of these 
tendencies. The variables that could predict a worse cognitive performance were a 
presence of cyanosis (p=.042) and a low value of head circumference, which has a p 














According to the results, it is possible to confirm one of our hypothesis, saying that 
adolescents with congenital heart disease, when compared to the control group, have 
lower performance in neuropsychological tasks in almost every dimension studied, with 
the exception of Weschler`s logical memory. What it is commonly found in current 
publications is that children with congenital heart disease, in fact, show lower 
performance in neuropsychological evaluation, in several cognitive domains.
7
  
Congenital heart disease children had more difficulties in auditory-verbal immediate 
attention tasks, selective attention (Stroop Test Word, Color and Interference) and 
divided attention (Trail Making Test – part B). This may be explained by previous 





and by results of behavioral assessment evaluation, by the 
parents of children with congenital heart disease, having described attention problems.
33 
As for Key Search Test, we came to the conclusion that congenital heart disease 
children have poorer performance. This may suggest some difficulties in executive 
functions, such as planning ability. Our results go along other studies that state the 
existence of alterations on executive functioning, planning ability, organization and 
problem resolution.
7,8,13,34
  Alterations on executive functioning are also consistent with 
low results in Trail Making Test – part B. 
In this study, we were able to verify that congenital heart disease patients show 
deficits in visual-constructive ability Rey’s Complex Figure – copy and visual-spatial 
(Rey’s Complex Figure - Memory e Trail Making Test – part A). According to Miatton 
et al
7
, Brosig et al
9
; Bellinger et al
2
; Bellinger et al
34
 , children with different types of 
congenital heart disease reveal difficulties in tasks involving visual-spatial abilities. 
Visual-spatial deficits may be implicated in perceptive organization.
2 
We also found that congenital heart disease patients have worse performance in 
visual memory tasks (Rey’s Complex Figure - memory) and working memory (Inverse 
Digits). 





; Majnemer et al
13
), more specifically in working memory
2
 and visual 
memory.
35
 In the mean time, other studies claim that congenital heart disease children 
do not have any memory deficits, when compared to healthy children.
35 
In this investigation were also made comparisons relating to performance in 
neuropsychological tests between the subgroups of congenital heart disease, particularly 
cyanotic cardiopathies (TF and TGA) and acyanotic cardiopathies (VSD). When 
comparing the 3 subgroups (cyanotic and acyanotic), as to performance on 
neuropsychological tests, we found that teens with cyanotic cardiopathy have worst 
results compared with the acyanotic group. However, the significant differences are 
only in RCFc, RCFm and StroopI. These results suggest that, in this way the cyanotic 
subgroup possible presents deficits in the visual construction ability, visual memory and 
selective attention. As Hovels-Gurich and collaborators
12
, in studies with children with 
cyanotic and acyanotic cardiopathies, there is a higher risk of attention dysfunction in 
children with cyanotic heart disease compared to acyanotic, corroborating this way part 
of the results of the present study, since although not significant, it is clear that on 
average, adolescents with TF and TGA show lower results than the adolescents with 
VSD. 
    Nevertheless, there are several studies not consistent with our results, which point in 
equality of neuropsychological performance between cyanotic and acyanotic subgroups 
.
 12,36,37,38, 39, 40 
    Concerning indices of fetal brain development (head circumference, weight and 
length) and neonatal parameters (Apgar 1 and 2) we know that these can indicate some 
vulnerability in mental and psychomotor development.
30
 So, since apparently there is a 
correlation between the fetal/neonatal parameters and neuropsychological abilities, it 
becomes important to study the correlations between these variables and cognitive 
performance in neuropsychological activities in adolescents with congenital heart 
disease. 
    Relatively though the results of the present investigation, it is concluded that the main 
correlation between indices of fetal brain development and cognitive development in 
long-term is notoriously in head circumference. This variable correlates positively with 
the immediate auditory-verbal attention, visual constructive ability, executive 
functioning (planning and problem-solving), selective attention and verbal immediate 
memory. Still in the head circumference it is denoted a negative correlation with visual-
spatial orientation and psychomotor speed. 
Being this fetal variable a likely indicator of a poor performance on cognitive 
activities, which involve the operation of the frontal lobe, and once, in the presence of 
congenital cardiopathies is often the compromise fetal oxygenation is, consequently 




With regard to weight variable, there was a positive correlation with the ability to 
visual constructing and executive functioning, especially with the planning ability and 
problem solving. In the literature, there are several studies that corroborate our findings, 




    As mentioned earlier, in the case of oxygenation problems, there is a global constraint 
of somatic growth, due to redistribution of brain circulation.
22, 43, 44
  This way there is a 
delay in fetal growth may have influence later in neurocognitive performance. 
    According to the results mentioned above, in which the head circumference correlates 
with much of neuropsychological tasks, this seems that fetal variable has a strong 
influence on neuropsychological performance of adolescents with congenital 
cardiopathies. 
   With regard to the different groups of congenital heart diseases (VSD, TF and TGA), 
can be verified the positive correlations that exist in VSD subgroup between the head 
circumference and planning ability and problems solving. These results suggest that 
children with congenital cardiopathies and low head circumference can have 
neurodevelopment consequences later
1, 45
, particularly in executive functions. 
    Even in this group, there is positive correlation between length variable and selective 
attention, a negative correlation between  head circumference with visuo-spatial 
orientation and psychomotor speed, and a positive correlation between weight and 
planning ability and problems solving. 
In the subgroup TF, there were positive correlations between the Apgar indice (2) 
and the selective attention, these results are supported by the commitment of fetal 
oxygenation manifest in congenital heart diseases. Even in this subgroup, were 
perceptible positive correlations between the weight and visual constructive ability. 
As for the TGA subgroup, there were positive correlations between Apgar scores, 1 and 
2, with the visuospatial orientation ability, psychomotor speed and divided attention. 
According to Massaro and collaborators
46
 the presence of congenital heart diseases in 
newborns is accompanied by hypoxic-ischemic lesions, detected by magnetic 
resonance
47
, being likely their relationship with low Apgar scores (1 and 2) which will 
later translate into difficulties on the cognitive performance of children.
 22, 44
  Even in 
the TGA subgroup, there was a negative correlation between the Apgar score (2) and 
work memory (WDI) and the psychomotor performance (WSS), which points towards a 
relationship between psychomotor performance in children with TGA and Apgar score 
(2).  
Analyzing the predictors of a worse cognitive performance, we conclude that the 
presence of cyanosis in these patients and a low head circumference reveal themselves a 
strong predictors of a worse cognitive performance in adolescents with congenital heart 
disease. 
    As such, according to our results it can be concluded that adolescents with congenital 
heart diseases exhibit a worse neurocognitive performance compared to healthy 
adolescents. It is also notorious the implications of fetal and neonatal parameters on 
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Table 1. Characteristics of the sample 
  
C CHD 
Age (M/SD) 15,69/ 1,44 15,09/ 1,71 
Gender 
(Male/Female) 11/5 43/34 
Education (M/SD) 10,13/1,36 9,13/1,95 
 
Table 2. Characteristics of the CHD subgroups with reference to the parameters of fetal 
development  
  TGA TF VSD 
Age (M/SD) 
14,91/1,95 15,17/1,8 15,16/1,43 
Gender (Male/Female) 16/7 13/10 14/17 
Education (M/SD) 8,91/2,03 9,3/ 2,12 9,16/1,79 
Head circumference 
(M/SD) 33,87/1,51 32,96/2,93 34,4/ 2,38 
APGAR 1 (M/SD) 8,06/ 1,2 7,82/ 2,01 7,5/ 2,39 
APGAR 2 (M/SD) 9,29/ 0,99 9,53/0,87 9,86/0,36 
Weight (M/SD)  3,17/0,44 2,87/ 0,76 3,21/0,66 
Length (M/SD) 48,05/2,55 46,79/5,25 48,11/3,11 
Table 3. Comparison of results obtained by the groups (CG and CHDG) in different 
neuropsychological tasks 




 Mean Rank Mean Rank u p 
WDD 69,09 42,41 262.5 <.001 
WDR 75,09 41,16 166.5 <.001 
RCFc 75,97 40,98 152.5 <.001 
 RCFm 76,19 40,94 149.0 <.001 
WSS 32,25 50,06 380.0 .016 
BKS 75,47 41,08 160.5 <.001 
StroopW 76,31 40,91 147.0 <.001 
StroopC 71,44 41,92 225.0 <.001 
StroopI 77,16 40,73 133.5 <.001 
TMT - A 14,22 53,81 91.5 <.001 
TMT - B 16,66 53,31 130.5 <.001 
MLT 52,50 45,86 528.0 .368 
Total 
Performance 
82,31 39,66 51.0 <.001** 
* p ≤ 0.05 ** p ≤ 0.01 











SD M SD M SD F p 
WDD 10,52 2,67 9,57 3,07 9,09 3,03 1,713 .187 
WDR 5,58 2,31 4,26 2,20 4.96 2,44 2,150 .124 
RCFc 31,45 7,09 29,11 7,89 28,46 6,39 1,341 .268 
RCFm 19,65 6,58 15,54 8,19 13,61 7,13 4,936 .010* 
WSS 53,42 18,65 49,30 16,45 51,52 12,52 0,418 .660 
BKS 7,10 3,76 6,04 2,95 5,91 2,94 1,073 .347 
StroopW 78,69 17,16 74,74 18,46 72,17 13,77 1,025 .364 
StroopC 63,35 12,91 58,96 12,32 59,39 11,03 1,095 .340 
StroopI 39,97 9,73 37,52 9,13 34,52 9,09 2,235 .114 
TMT-A 46,10 28.44 52,13 27,85 46,96 13,70 0,430 .652 
TMT-B 78,06 43,07 94,09 48,64 84,91 35,73 0,924 .402 
MLT 13,10 5,18 11,52 4,43 11,35 4,04 1,194 .309 
Total 
Performance 
0,46 7,91 -3,53 8,12 -3,64 6,68 2,609 .080 
* p ≤ 0.05 ** p ≤ 0.01 
 
Table 5. Spearman's correlation between indices of fetal brain development and 
neonatal parameters and the results of neuropsychological tests in CHD group. 
 
* p ≤ 0.05 ** p ≤ 0.01 













  rho p rho p rho p rho p rho p 
WDD -.044 .735 .216 .092 .339* .011 .064 .610 .078 .523 
WDR -.179 .163 -.037 .772 .260 .055 -.044 .729 .067 .583 
RCFc -.172 .182 .147 .253 .297* .027 .207 .095 .254* .035 
RCFm -.228 .075 .166 .197 .091 .507 .040 .752 .100 .414 
WSS -.196 .126 -.066 .611 -.017 .901 .095 .448 .060 .626 
BKS -.182 .157 -.059 .648 .264 .051 .128 .306 .340** .004 
StroopW .052 .688 .245 .055 .231 .089 .185 .136 .089 .467 
StroopC -.015 .906 .158 .220 .256 .059 .115 .356 .144 .239 
StroopI .164 .203 .207 .107 .283* .036 .122 .329 .076 .535 
TMT-A .062 .631 -.014 .915 -.321* .017 -.015 .908 -.147 .227 
TMT-B .081 .531 .024 .853 -.127 .355 -.012 .926 -.148 .224 
MLT -.211 .099 .035 .789 .263 .052 .197 .114 .177 .146 
Total 
Performance 
-.181 .160 .121 .351 .361** .007 .130 .298 .232 .055 
Table 6. Spearman's correlation between indices of fetal brain development and 














 rho p rho p rho p rho p rho p 
WDD -.110 .578 .204 .298 .154 .454 .012 .952 .038 .846 
WDR -.214 .274 -.108 .583 .149 .467 -.134 .498 -.172 .373 
RCFc -.092 .642 .077 .698 .145 .479 .309 .110 .236 .217 
 RCFm -.260 .292 .177 .367 .178 .384 .056 .776 .126 .516 
WSS -.296 .127 -.013 .949 -.078 .704 .200 .307 .170 .378 
BKS -.035 .860 .204 .297 .463* .017 .082 .677 .518** .004 
StroopW -.041 .835 .278 .152 .108 .601 .428* .023 -.289 .128 
StroopC -.046 .815 .139 .480 .221 .277 .269 .166 .232 .226 
StroopI .282 .146 .209 .285 .186 .363 .249 .201 .178 .355 
TMT - A -.038 .849 -.165 .403 -.397* .045 -.335 .082 -.333 .077 
TMT - B -.003 .987 -.051 .798 .020 .923 .008 .968 -.197 .305 
MLT -.120 .543 .013 .949 .305 .130 .115 .560 .333 .078 
* p ≤ 0.05 ** p ≤ 0.01 
 
 
Table 7. Spearman's correlation between fetal brain development indices and 














 rho p rho p rho p rho p rho p 
WDD .127 .627 .406 .106 .506 .065 .141 .564 .317 .162 
WDR .012 .963 .221 .393 .478 .084 .166 .496 .366 .102 
RCFc -.297 .247 .210 .418 .358 .209 .371 .118 .458* .037 
 RCFm -.343 .177 .073 .782 .067 .820 -.024 .922 .160 .490 
WSS -.003 .992 .101 .700 .245 .399 .015 .952 .077 .741 
BKS -.270 .295 -.223 .389 .300 .298 .143 .559 .149 .519 
StroopW .323 .206 .523* .031 .316 .272 .184 .450 .016 .946 
StroopC .267 .301 .559* .020 .357 .211 .212 .384 .256 .263 
StroopI .178 .495 .378 .134 .507 .064 .087 .724 .150 .516 
TMT - A .023 .929 -.103 .694 -.129 .659 .216 .374 -.030 .899 
TMT - B -.102 .696 -.171 .512 -.374 .187 .007 .977 -.120 .604 
MLT -.280 .276 .030 .909 .286 .321 .096 .694 .004 .985 
* p ≤ 0.05 ** p ≤ 0.01 
 
 
Table 8. Spearman's correlation between fetal brain development indices and 














 rho p rho p rho p rho p rho p 
WDD -.130 .618 -.204 .432 .366 .180 .059 .812 -.239 .324 
WDR -.430 .085 -.506* .038 .208 .457 -.079 .748 -.016 .948 
RCFc -.181 .487 -.164 .529 .290 .294 -.322 .179 -.144 .556 
RCFm -226 .383 -.329 .197 -.261 .347 -.169 .490 -.293 .223 
WSS -.448 .072 -.502* .040 -.241 .387 -.023 .924 -.141 .564 
BKS -.261 .312 -.103 .693 -.146 .604 .017 .944 .229 .346 
StroopW -.182 .485 -.223 .389 .432 .108 -.252 .298 -.203 .405 
StroopC -.298 .246 -.339 .184 .184 .511 -.379 .110 -.310 .197 
StroopI -.082 .755 -.265 .304 .145 .605 -.243 .317 -.395 .094 
TMT - A .273 .290 .446 .073 -.273 .326 .291 .226 .242 .318 
TMT - B .565* .018 .584* .014 -.002 .995 .210 .389 .120 .624 
MLT -.206 .424 -.133 .610 -.085 .764 .423 .071 .094 .701 
* p ≤ 0.05 ** p ≤ 0.01 
 
 
Table 9. Linear Regression: Cyanosis and head circumference are the main 
predictors of neuropsychological performance in CHD patients in adolescence. 
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Resumo 
Objetivos: O objetivo deste estudo foi avaliar a performance neurocognitiva em 
adolescentes com cardiopatia congénita e determinar se os parâmetros de 
desenvolvimento fetal avaliados em recém-nascidos, tais como o perímetro cefálico, 
comprimento,  peso e índices de Apgar, estão de alguma forma relacionados com o seu 
desempenho neurocognitivo. 
Método: Foram avaliados 77 pacientes com Cardiopatia Congénita (43 homens) com 
idades compreendidas entre os 13 e 18 anos de idade (x= 15,04 ± 1,86), sendo que 46 
são cianóticos. O grupo controle incluiu 16 crianças saudáveis (11 homens) com idades 
entre 13 e 18 anos (x= 15,69 ± 1,44). Os testes neuropsicológicos selecionados foram 
administrados a ambos os grupos, envolvendo uma ampla gama de funções 
neurocognitivas, como a memória a curto prazo (verbal e visuo-construtiva), memória 
de trabalho, velocidade de processamento, atenção (dividida e seletiva) e planeamento.  
Resultados: Pacientes coronários em comparação ao grupo controlo apresentaram 
resultados inferiores na totalidade das provas, exceto na prova Memória Lógica. Os 
pacientes com CIV quando comparados com os pacientes com TF e TGA, apresentaram 
melhores resultados em todas as provas neuropsicológicas, embora as únicas diferenças 
significativas foram na prova FCRc (F=4,936; p=.010). Diversas correlações eram 
aparentes entre os parâmetros fetais/neonatais e as capacidades neuropsicológicas nos 
diferentes subgrupos de cardiopatias. No entanto, a principal correlação verifica-se entre 
o perímetro cefálico e as provas Dígitos Diretos (rho=.339; p=.011), Figura Complexa 
de Rey (rho=.297; p=.027), Stroop Interferências (rho=.283; p=.036) e Trail Making 
Test (rho=-.321; p=.017).  
Conclusão: Adolescentes com cardiopatia congénita apresentam um pior desempenho 
neuropsicológico comparativamente ao grupo controlo, principalmente os pacientes 
cianóticos (TF e TGA). A circulação fetal parece ter um forte impacto sobre o 
crescimento cerebral e somático, prevendo um comprometimento cognitivo em 
adolescentes com cardiopatias congénitas. 
 
Palavras Chave: Desenvolvimento Fetal, Funcionamento Neurocognitivo, Variáveis 







A doença cardíaca congênita tem sido considerada a causa mais comum de 
morbilidade e mortalidade infantil.
1
 
Nas últimas décadas, os avanços nas intervenções cirúrgicas e tratamento em 
pacientes com doença cardíaca congénita, têm contribuído para o aumento da 
expectativa de vida dessas crianças. No entanto, mais de metade dessas crianças irão 
apresentar algum tipo de dano neurológico.
2,3,4 
Na literatura, diferentes estudos apontam para a existência de alterações no 
desenvolvimento cognitivo de jovens com cardiopatias congénitas, consequências estas 
relacionadas com fatores peri operatórios (síndromes, circulação extra corporal durante 
a cirurgia e complicações pós-cirúrgicas).
5
 
 Um grande número de crianças que foram submetidas a cirurgia cardíaca no período 
neonatal, demonstraram um padrão de desenvolvimento de problemas neurológicos, 
caracterizados por défices cognitivos, de atenção e funcionamento executivo, de 
capacidades visuo-motoras e visuo-espaciais, de atraso na aquisição da linguagem 
expressiva e de dificuldades de aprendizagem.
6,7,8,9,10,11,12,13
 A maioria dos estudos que 
focam os resultados neurológicos em crianças com cardiopatias congénitas, salientam os 
fatores relacionados com a cirurgia, especificamente quando a perfusão cerebral pode 
estar comprometida durante a circulação extra corporal 
1
sendo que estes fatores, foram 
considerados percursores de possíveis complicações neurocognitivas.
14
 No entanto, 
outros estudos demostram uma alta prevalência de anormalidades neurológicas 
anatómicas e funcionais antes da cirurgia em recém-nascidos com cardiopatia 
congénita
15,16,17
, focando a relação entre estas anormalidades e o desenvolvimento 
cognitivo durante a infância.  
Conforme alguns estudos, foram encontradas anormalidades neurocomportamentais 
como hipotonia, agitação/inquietação, assimetria motora, letargia e características autistas, 
anteriores à cirurgia em mais de 50% dos recém-nascidos (menos de um mês) e 38% de 
crianças (entre 1 mês e 2 anos de idade) com cardiopatias congénitas.
 18,19
 São ainda 
diagnosticadas no período pré operatório, a presença de agenesia ou disgenesia do corpo 
caloso, holoprosencefalia, microcefalia, lisencefalia
20
, abertura do opérculo, enfartes 
isquémicos e lesão da substancia branca caracterizada por leucomalácia 
periventricular.
21
 Estes estudos concluíram ainda que essas anormalidades persistiam ou 




Os recém-nascidos com cardiopatia congénita apresentam potenciais riscos de 
apresentarem hipoxia, hipotensão e acidose. A presença de hipoxia-isquémica num 
período pré-natal (desenvolvimento fetal) pode causar complicações no 
desenvolvimento neurológico a longo prazo. 
A hipoxia fetal afeta o desenvolvimento normal do cérebro, nomeadamente ao nível 
do hipocampo (estrutura cerebral responsável pela conversão da memória a curto-prazo 
em memória a longo prazo) e do córtex cerebral (estrutura cerebral responsável pelas 
áreas cognitivas relacionadas com a memória, atenção, linguagem, perceção e 
pensamento).
22
 Este facto revela a possibilidade de as malformações cardíacas 
congénitas e as anomalias no crescimento fetal estejam causalmente relacionadas.
23,17
 
Com isto, mantem-se ainda a hipótese de que as anormalidades do desenvolvimento 
cerebral, as alterações hemodinâmicas intrauterinas, as anormalidades cerebrais 
congénitas e lesões cerebrais adquiridas, relacionadas com cianose prolongada e 
hipoperfusão após o nascimento
1
, contribuem para efeitos adversos no desenvolvimento 
neurológico em crianças com cardiopatia congénita.
15
  
Vários estudos de ressonância magnética realizados num período peri-operatório, 
corroboram que os recém-nascidos com cardiopatias congénitas apresentam uma alta 
frequência de lesão cerebral adquirida e lesão da substância branca. Estas anormalidades 
no desenvolvimento cerebral em recém-nascidos com cardiopatias congénitas podem 
refletir anormalidades no fluxo sanguíneo cerebral do feto e consequentemente um 
atraso no desenvolvimento do cérebro.
24
  
Uma vez que muitos recém-nascidos apresentam a cardiopatia congénita como 
patologia isolada, supõe-se que o cérebro apresenta um potencial de desenvolvimento 
normal.
25
 Contudo, é de realçar que o cérebro e o coração compartilham vias genéticas 
comuns, ocorrendo o seu desenvolvimento em simultâneo no feto com cardiopatia 
congénita. 
Por volta da sétima semana de gestação, o coração torna-se morfologicamente 
maduro enquanto que o desenvolvimento cerebral prolonga-se ao longo de um período 
de tempo mais alargado. É durante este período que decorrem diversos eventos 
morfológicos durante os primeiros dois trimestres
24
, nomeadamente a migração e 
arborização neuronal, sinaptogénese, morte celular programada, maturação dos 
oligodendrócitos e extensa reorganização das conexões sinápticas.
15
 Após este período 
ocorre um crescimento cerebral marcante e dependente da formação e aperfeiçoamento 
de conexões no terceiro trimestre e período pós-natal.
24
 Esta fase de desenvolvimento 
caracterizada por um visível aumento da atividade metabólica, torna o cérebro 
dependente do coração para o fornecimento de oxigénio e de nutrientes. 
A presença de cardiopatias congénitas leva a anormalidades no fluxo sanguíneo fetal, 
nomeadamente alterações na dinâmica de distribuição de oxigénio no cérebro em 
desenvolvimento.
24
 Com isto, torna-se evidente a importância destes fatores no 
crescimento e maturação cerebral.
26
 
Na circulação sanguínea normal do feto, as trocas gasosas ocorrem através da 
placenta. Enquanto que o sangue venoso desloca-se da veia cava inferior hepática para o 
ventrículo direito, o sangue oxigenado dirige-se do canal venoso sobre o forâmen oval 
através do ventrículo esquerdo para a aorta e circulação cerebral. Porém, quando a 
oxigenação fetal se encontra comprometida, há uma redistribuição sanguínea para a 
circulação cerebral, fenómeno este designado de “brain sparing”.1  Este fenómeno 
conhecido pela restrição global do crescimento somático, com relativa preservação do 
crescimento da cabeça
24
, é caracterizado pelo aumento do fluxo diastólico nas artérias 
cerebrais e pela diminuição do fluxo diastólico nas artérias aorta descendente e 
umbilical.
1
 No entanto, supõe-se que existem regiões específicas do cérebro, que se 
encontram mais protegidas do que outras. Conforme Dubiel, Gunnarsson & 
Gunnarsson
27
, num estudo realizado com grávidas com hipertensão materna e disfunção 
da placenta, verificou-se vasodilatação cerebral em 41% na artéria cerebral anterior, em 
30% na artéria cerebral posterior e em 24% na artéria cerebral média. Com os resultados 
deste estudo, concluiu-se que as artérias cerebrais anteriores apresentam uma melhor 
resposta autorreguladora, na qual a redistribuição do fluxo sanguíneo favorece a 
perfusão dos lobos frontais, ao contrário das artérias cerebrais médias que apresentam-
se menos reativas.
1
 Uma vez que a vasodilatação cerebral ocorre quando a oxigenação 
fetal está comprometida, este mecanismo de proteção pode ser insuficiente para manter 
o crescimento e desenvolvimento cerebral normal em situações de stress prolongado in 
útero. 
 Na circulação sanguínea fetal normal, o sangue oxigenado é conduzido para o 
cérebro e o sangue desoxigenado para a placenta.
1
 No entanto, e como referido 
anteriormente, estudos demonstram que a existência de anormalidades na circulação 
sanguínea, consequentes de cardiopatias complexas, nomeadamente no Síndrome 
Hipoplásico do Coração Esquerdo, Transposição Das Grandes Artérias, Tetralogia de 
Fallot, podem contribuir para um desenvolvimento cerebral anormal.
1,15, 24
  
Segundo Donofrio & Massaro
1
 o tipo de lesão não só afeta a origem do fluxo 
sanguíneo cerebral, mas também o grau de sangue desoxigenado distribuído através da 
circulação cerebral. Considera-se que em fetos com Síndrome Hipoplásico do Coração 
Esquerdo é provável um aumento da resistência ao fluxo cerebral, no qual a circulação 
sanguínea retrocede através de uma hipoplasia istmo-aórtica para chegar ao cérebro; na 
presença de Transposição de Grandes Artérias, o sangue venoso da circulação cerebral 
volta diretamente para o cérebro do feto, ao passo que em fetos diagnosticados com 
Tetralogia de Fallot e Síndrome Hipoplásico do Coração Direito, o sangue 
relativamente desoxigenado entra na circulação cerebral devido à mistura intracardíaca. 
Assim, todas estas alterações na circulação sanguínea poderão ser percursores de um 
crescimento somático anormal in útero, influenciando a antropometria neonatal.
23
  
Comparando recém-nascidos sem patologia congénita cardíaca e recém-nascidos 
com Síndrome Hipoplásico do Coração Esquerdo, os últimos apresentam peso, 
comprimento e perímetro cefálico inferiores aos parâmetros normais e o volume da 
cabeça é desproporcionalmente pequena comparativamente ao peso. No que diz respeito 
aos recém-nascidos com Transposição das Grandes Artérias, estes apresentam peso 
dentro dos parâmetros normais, ao contrário do perímetro cefálico que se apresenta 
inferior relativamente ao peso, uma vez que Rivkin e colaboradores mencionam que 
adolescentes com TGA sujeitos a cirurgia do tipo "arterial switch", nos primeiros meses 
de vida, apresentam anormalidades da substancia branca, nomeadamente a redução da 
mesma.
28
 Contudo, os recém-nascidos com Tetralogia de Fallot têm proporções 
normais, apresentando no entanto, peso, comprimento e perímetro cefálico inferiores 
aos parâmetros normais. Em crianças com diagnóstico de Coartação da Aorta, observa-




Deste modo, considera-se que são vários os fatores que contribuem para um baixo 
peso ao nascimento, nomeadamente os síndromes genéticos, insuficiência placentária e 
restrição do crescimento intra-uterino, e que possivelmente poderão aumentar o risco de 
atrasos no neurodesenvolvimento.  
Conforme Gaynor, Jarvik, Bernbaum, Gerdes, Wernovsky et al
30
, em estudos 
recentes, os fatores inerentes ao paciente, nomeadamente peso à nascença, perímetro 
cefálico ao nascer e índices de Apgar no 1º e no 5º minuto, revelam-se melhores 
preditores da vulnerabilidade do índice de desenvolvimento mental e psicomotor, 
comparativamente aos fatores intraoperatórios (peso na cirurgia, tempo de resfriamento, 
paragem circulatória por hipotermia profunda, duração da circulação extracorporal e 
baixa temperatura nasofaríngea). 
 
Amostra e Método 
A amostra é composta por 93 participantes, entre 13 e 18 anos de idade, divididos em 
dois grupos: um grupo de adolescentes com cardiopatia congênita (CC), composto por 
77 pacientes recrutados no serviço de cardiologia pediátrica do ambulatório do Hospital 
de São João (Porto); e um grupo controle (GC), composto por 16 adolescentes de várias 
escolas na área da cidade do Porto (Tabela 1). O grupo CC é dividido em três grupos, 
correspondentes a diferentes tipos de doença cardíaca congênita: Transposição das 
Grandes Artérias (TGA) (n = 23), Tetralogia de Fallot (TF) (n = 23) e Comunicação 
Interventricular (CIV) (n = 31). As Tabelas 1 e 2 mostram as características da amostra. 
O grupo controle e o grupo CC não diferem relativamente à idade (p = .197), género 
(χ2 = .906, p = .412) e anos de escolaridade (p = .055). O mesmo é válido para os três 
subgrupos de CC relativamente à idade (H = .420, p = .811), género (χ2 = 3,195, p = 
.202) e anos de escolaridade (H = .531, p = .767). 
 
Avaliação Neuropsicológica 
A fim de recolher todas as informações necessárias para este estudo, todos os 
participantes foram submetidos a uma breve avaliação neuropsicológica, desenhada para 
avaliar uma série de funções neurocognitivas durante um curto período de tempo. 
Diferentes testes foram utilizados para este fim, tais como, a subprova Memória de 
Dígitos Diretos (DD) e Inversos (DI), com foco na avaliação da atenção auditivo-verbal 
imediata e memória de trabalho, respetivamente; a subprova Código (Cd)  parte B usada 
para avaliar o desempenho psicomotor, velocidade de execução, organização perceptiva. 
Figura Complexa de Rey, cópia (FCRc) e reprodução (FCRm) por memória três 
minutos após a exposição da imagem, teste utilizado para avaliar a capacidade de 
construção visual e memória visual. O teste Procura da Chave (PC), da bateria 
Behavioural Assessment of the Dysexecutive Syndrome (BADS), centra-se na avaliação 
da capacidade para o planeamento e resolução de problemas. 
O teste Stroop - Cor (StroopC), Palavra (StroopP) e Interferência (StroopI) foi 
utilizado para avaliar a capacidade de atenção seletiva. O Trail Making Test - parte A 
(TMT-A) e B (TMT-B), centra-se na avaliação da orientação visuo-espacial e 
velocidade psicomotora (TMT A), enquanto que o TMT B avalia a atenção dividida. 
Finalmente, a Memória Lógica da Wechsler (ML) foi utilizada para avaliar a 






A análise estatística foi realizada através do programa IBM SPSS Statistics para o 
Windows, versão 21.0. Inicialmente no sentido de caracterizar a amostra e estabelecer a 
comparação entre os resultados obtidos nos testes neuropsicológicos pelos quatro 
grupos foi realizada uma análise descritiva. No sentido de comparar os resultados nas 
provas neuropsicológicas, entre o Grupo Controlo e Grupo de Cardiopatias Congénitas 
e ainda entre os subgrupos de CC, foi utilizado a teste não paramétrico U de Mann-
Whitney. 
Posteriormente, as correlações de Spearman foram utilizadas para correlacionar 
variáveis fetais (peso, comprimento e perímetro cefálico) e as variáveis neonatais 
(Apgar 1 e 2) com os resultados obtidos pelo o grupo e subgrupos de CC.  
Finalmente, foi realizada uma análise de regressão no sentido de determinar a relação 
entre as variáveis independentes (perímetro cefálico e presença/ausência de cianose) e o 




Relativamente à performance dos grupos Controlo e CC, nas provas 
neuropsicológicas, verificamos através da Tabela 3 as diferenças significativas no 
desempenho neurocognitivo entre os grupos, com melhores resultados na performance 
do GC, com exceção da subprova Memória Lógica da Wechsler. 
Na tabela 4 é apresentada a comparação dos resultados obtidos nas provas 
neuropsicológicas pelos subgrupos de CC (CIV, TF e TGA). Assim, verificamos que o 
subgrupo CIV apresenta resultados superiores aos adolescentes com cardiopatias 
cianóticas (TF e TGA), apresentando-se apenas como diferença significativa no que 
concerne ao desempenho neuropsicológico na prova FCRm (p=.010). 
Com o objetivo de verificar a existência de uma correlação significativa entre índices 
de desenvolvimento cerebral fetal e parâmetros neonatais e o desempenho cognitivo nas 
provas neuropsicológicas administradas, no grupo e subgrupos de CC, utilizou-se a 
correlação ordinal de Spearman (rho), uma vez que a distribuição da amostra não é 
homogénea. 
Face à análise da tabela 5 observa-se que, no grupo CC os índices de 
desenvolvimento cerebral fetal correlacionam-se positiva e estatisticamente significativa 
com as seguintes provas neuropsicológicas: perímetro cefálico com DD (rho=.339; 
p=.011), FCRc (rho=.297; p=.027) e StroopI (rho=.283; p=.036); peso com FCRc 
(rho=.254; p=.035) e PC (rho=.340; p=.004). Ainda neste grupo, a variável perímetro 
cefálico correlaciona-se negativa e estatisticamente significativa com a prova TMT-A 
(rho=-.321; p=.017). 
De acordo com a tabela 6, verifica-se que no subgrupo CIV, as variáveis fetais 
correlacionam-se de forma positiva e estatisticamente significativa com as seguintes 
provas neuropsicológicas: perímetro cefálico com PC (rho=.463; p=.017), comprimento 
com StroopP (rho=.428; p=.023) e peso com PC (rho=.518; p=.004). Ainda neste grupo, 
a variável perímetro cefálico correlaciona-se negativa e estatisticamente significativa 
com a prova TMT-A (rho=-.397; p=.045). 
Pela análise da tabela 7 é possível verificar que, no subgrupo TF, a variável neonatal 
Índice Apgar (2) correlaciona-se de forma positiva e estatisticamente significativa com 
a prova StroopP (rho=.523; p=.031) e StroopC (rho=.559; p=.020). A variável peso 
correlaciona-se positiva e estatisticamente significativa com a prova FCRc (rho=.458; 
p=.037). 
Pela análise da tabela 8 verifica-se que, no subgrupo TGA, a variável neonatal, 
Índice Apgar (1) correlaciona-se positiva e estatisticamente significativa com a prova 
TMT-B (rho=.565; p=.018) enquanto o Índice Apgar (2) correlaciona-se de forma 
positiva e estatisticamente significativa com a prova TMT-B (rho=.584; p=.015). Ainda 
neste grupo, o Índice Apgar (2) correlaciona-se negativa e estatisticamente significativa 
com a prova DI (rho=-.506; p=.038) e Cd (rho=-.502; p=.040). 
Finalmente, realizada a análise de regressão pudemos confirmar algumas dessas 
tendências. Assim, as variáveis que poderiam prever uma pior performance cognitiva 
foram a presença de cianose (p=.042) e um valor abaixo para o perímetro cefálico, que 
apesar de não ser estatisticamente significativo, encontra-se muito próximo de ser 
significativo (p=.053) (tabela 9).  
 
Discussão 
De acordo com a análise dos resultados obtidos, quando comparamos a performance nas 
provas neuropsicológicas do grupo de adolescentes com CC com o grupo de 
adolescentes saudáveis, verificamos que o primeiro apresenta um desempenho inferior 
em quase todas as dimensões neuropsicológicas estudadas, exceto na subprova  
Memória Lógica da Wechsler. São vários os estudos que corroboram a ideia que, de 
facto as crianças com cardiopatias congénitas, demonstram um baixo desempenho na 
avaliação neuropsicológica, em vários domínios cognitivos.
7 
É de facto notório no desempenho do grupo de CC a existência de dificuldades ao 
nível da atenção auditivo-verbal imediata (Dígitos Diretos), atenção seletiva (Stroop) e 
atenção dividida (prova TMT B). Estes resultados foram confirmados por estudos 
prévios, em que os pacientes com cardiopatias congénitas obtiveram desempenhos 
inferiores em tarefas que requerem domínios atencionais
7,8,9,10,31,32
  e pelos produtos 
obtidos na avaliação comportamental efetuada pelos pais de crianças com cardiopatias 
congénitas, onde descrevem problemas atencionais por parte dos filhos.
33
  
Quanto à prova PC, verificamos que os adolescentes com cardiopatias congénitas 
apresentam uma pior performance. Este dado sugere dificuldades ao nível do 
funcionamento executivo, nomeadamente na capacidade de planeamento. Os resultados 
são corroborados por estudos que referem a existência de alterações no funcionamento 
executivo, principalmente na capacidade de planeamento, organização e resolução de 
problemas
7,8,13,34
 As alterações no funcionamento executivo também são consistentes 
com os baixos resultados na prova TMT B.  
Relativamente à prova Cd, observamos um pior desempenho dos adolescentes com 
cardiopatias congénitas, o que indica dificuldades mais uma vez, ao nível do 
desempenho psicomotor, mas ainda da velocidade de execução e organização percetiva.  
Assim, de acordo com os resultados obtidos, verificamos que os adolescentes com 
cardiopatias congénitas apresentam défices ao nível da capacidade visuo-construtiva 
(Figura Complexa de Rey - Cópia) e visuo-espacial (Figura Complexa de Rey - 
Memória e TMT A). Segundo Miatton et al
7
, Brosig et al
9
; Bellinger et al
2
; Bellinger et 
al
34
 crianças com diferentes tipos de CC revelam dificuldades em tarefas que envolvem 
a capacidade visuo-espacial. Os défices visuo espaciais, parecem estar implicados em 
alterações ao nível da organização percetiva
2
  
Os nossos resultados, demostraram também que o grupo de cardiopatias congénitas 
apresenta um pior desempenho nas provas que avaliam a memória visual (Figura 
Complexa de Rey - Memória) e a memória de trabalho (Dígitos Inversos). Existe uma 
consistência destes resultados com alguns estudos existentes na literatura, onde 
mencionam que crianças com cardiopatias congénitas apresentam défices de memória 
(Bellinger et al
2
; Miatton et al
7
; Majnemer et al
13
), sobretudo ao nível da memória de 
trabalho
2
 e memória visual.
35
 No entanto, outros estudos mencionam que crianças com 




Nesta investigação foram também efetuadas comparações relativas ao desempenho 
nas provas neuropsicológicas entre os subgrupos de cardiopatias congénitas, 
nomeadamente cardiopatia cianótica (grupo TF e TGA) e cardiopatia acianótica (grupo 
CIV).  Quando comparados os 3 subgrupos (cianótico e acianótico), quanto à 
performance nas provas neuropsicológicas, verificamos que os adolescentes com 
cardiopatia cianótica apresentam piores resultados comparativamente com os 
acianóticos. No entanto, as diferenças significativas apresentam-se apenas na prova 
FCRm. Estes resultados sugerem deste modo que, os subgrupos cianóticos apresentam 
possíveis défices ao nível da capacidade de construção visual e memória visual. 
Conforme Hovels-Gurich e colaboradores
12
, em estudos efetuados com crianças com 
cardiopatia cianótica e acianótica, existe um maior risco de disfunção atencional em 
crianças com cardiopatia cianótica comparativamente às acianóticas, corroborando deste 
modo parte dos resultados do presente estudo, uma vez que apesar de não serem 
significativos, é notório que em média, os adolescentes com TF e TGA apresentam 
resultados inferiores aos adolescentes com CIV. 
No entanto, existem diversos estudos não consistentes com os nossos resultados, que 
apontam na igualdade da performance neuropsicológica entre os subgrupos cianótico e 
acianótico. 
12,36,37,38, 39, 40 
No que diz respeito aos índices de desenvolvimento cerebral fetal (perímetro 
cefálico, peso e comprimento) e parâmetros neonatais (Apgar 1 e 2) sabemos que estes 
podem indicar alguma vulnerabilidade no desenvolvimento mental e psicomotor.
30
 
Assim, uma vez que aparentemente existe uma correlação entre os parâmetros 
fetais/neonatais e as capacidades neuropsicológicas, torna-se importante estudar as 
correlações existentes entre essas variáveis e o desempenho cognitivo em atividades 
neuropsicológicas em adolescentes com doença cardíaca congênita. 
Relativamente aos resultados da presente investigação, conclui-se que a principal 
correlação entre os índices de desenvolvimento fetal cerebral e o desenvolvimento 
cognitivo a longo prazo verifica-se notoriamente no perímetro cefálico. Esta variável 
correlaciona-se positivamente com a atenção auditivo-verbal imediata, capacidade 
construtiva visual, funcionamento executivo (planeamento e resolução de problemas), 
atenção seletiva e memória imediata verbal. Ainda na variável perímetro cefálico 
denotou-se uma correlação negativa com orientação visuo-espacial e velocidade 
psicomotora. 
Sendo esta variável fetal um provável indicador de um baixo desempenho em 
atividades cognitivas, que implicam o funcionamento do lobo frontal, e uma vez que, na 
presença de cardiopatica congénita é frequente o comprometimento da oxigenação fetal, 
fica assim prejudicado o mecanismo de autorregulação da circulação sanguínea de áreas 
cerebrais, nomeadamente dos lobos frontais.
 1 
No que diz respeito à variável fetal peso, verificou-se uma correlação positiva com a 
capacidade de construção visual e com o funcionamento executivo, nomeadamente com 
a capacidade de planeamento e resolução de problemas. Na literatura, são vários os 
estudos que corroboram os nossos resultados, uma vez que indicam uma forte relação 
entre o baixo peso à nascença com alterações das capacidades cognitivas.
41, 42 
Como mencionado anteriormente, no caso de problemas de oxigenação, há uma 
restrição global de crescimento somático, devido à redistribuição da circulação 
cerebral.
22, 43, 44
 Deste modo, um atraso no crescimento fetal pode ter influência no 
desempenho neurocognitivo a longo prazo. 
De acordo com os resultados mencionados anteriormente, em que a variável fetal 
perímetro cefálico se correlaciona com grande parte das provas neuropsicológicas, 
indicia-se que esta variável fetal tem uma forte influência no desempenho 
neuropsicológico dos adolescentes com cardiopatias congénitas. 
No que diz respeito aos diferentes grupos de cardiopatias congênitas (CIV, TF e 
TGA), verificou-se quanto ao subgrupo CIV que existem correlações positivas entre a 
variável fetal perímetro cefálico e a capacidade de planeamento e resolução de 
problemas. Estes resultados indiciam que crianças com cardiopatias congénitas e com 
baixo perímetro cefálico, podem ter consequências neurodesenvolvimentais a longo 
prazo
 1, 45
,  nomeadamente nas funções executivas.  
Ainda neste grupo, verifica-se correlação positiva entre a variável fetal comprimento 
e a atenção seletiva, uma correlação negativa entre a variável perímetro cefálico com a 
orientação visuo-espacial e a velocidade psicomotora e uma correlação positiva entre a 
variável peso e a capacidade de planeamento e resolução de problemas. 
No subgrupo TF, verificaram-se correlações positivas entre o índice de Apgar(2) e a 
atenção seletiva, resultados estes suportados pelo comprometimento de oxigenação fetal 
manifesto nas cardiopatias congénitas. Ainda neste subgrupo, foram percetíveis 
correlações positivas entre a variável peso e a capacidade construção visuo-espacial. 
Quanto ao subgrupo TGA, verificaram-se correlações positivas entre as variáveis 
neonatais Apgar 1 e 2, com a capacidade de orientação visuo-espacial, velocidade 
psicomotora e atenção dividida. Segundo Massaro e colaboradores
46
 a presença de 
cardiopatias congénitas em recém-nascidos é acompanhada de lesões hipoxico-
isquémicas detetadas por ressonância magnética
47
, sendo provável a sua relação com os 
baixos índices de Apgar (1 e 2) que, mais tarde se traduzem em dificuldades no 
desempenho cognitivo dessas crianças.
22, 44
 Ainda no subgrupo TGA, verificou-se uma 
correlação negativa entre o índice de Apgar(2) e a memória de trabalho (DI) e 
desempenho psicomotor (Cd), o que aponta no sentido  de uma relação entre o 
desempenho psicomotor em crianças com TGA e o índice de Apgar(2). 
Analisando os preditores de uma pior performance cognitiva, concluímos que a 
presença de cianose nestes pacientes e um baixo perímetro cefálico revelam-se fortes 
preditores de uma pior performance cognitiva em adolescentes com cardiopatia 
congénita. 
Assim, de acordo com os nossos resultados é possível concluir que adolescentes com 
cardiopatias congénitas apresentam um pior desempenho neurocognitivo 
comparativamente com adolescentes saudáveis. É ainda notório as implicações dos 
parâmetros fetais e neonatais no desempenho neurocognitivo destes adolescentes a 
longo prazo. 
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Tabelas 
Tabela 1. Características da amostra  
  
GC GCC 
Idade (M/DP) 15,69/ 1,44 15,09/ 1,71 
Género 
(Masculino/Feminino) 11/5 43/34 
Educação (M/DP) 10,13/1,36 9,13/1,95 
 
 
Tabela 2. Características dos subgrupos CC referentes aos parâmetros de 
desenvolvimento fetal  
  TGA TF CIV 
Idade (M/DP) 14,91/1,95 15,17/1,8 15,16/1,43 
Género (Masculino/Feminino) 16/7 13/10 14/17 
Educação (M/DP) 8,91/2,03 9,3/ 2,12 9,16/1,79 
Perímetro Cefálico (M/DP) 33,87/1,51 32,96/2,93 34,4/ 2,38 
APGAR 1 (M/DP) 8,06/ 1,2 7,82/ 2,01 7,5/ 2,39 
APGAR 2 (M/DP) 9,29/ 0,99 9,53/0,87 9,86/0,36 
Peso (M/DP)  3,17/0,44 2,87/ 0,76 3,21/0,66 
Comprimento (M/DP) 48,05/2,55 46,79/5,25 48,11/3,11 
Tabela 3. Comparação dos resultados obtidos pelos grupos (GC e GCC) nas 
diferentes provas neuropsicológicas.  




 Mean Rank Mean Rank u p 
DD 69,09 42,41 262.5 <.001** 
DI 75,09 41,16 166.5 <.001** 
FCRc 75,97 40,98 152.5 <.001** 
 FCRm 76,19 40,94 149.0 <.001** 
Cd 32,25 50,06 380.0 .016* 
PC 75,47 41,08 160.5 <.001** 
StroopP 76,31 40,91 147.0 <.001** 
StroopC 71,44 41,92 225.0 <.001** 
StroopI 77,16 40,73 133.5 <.001** 
TMT - A 14,22 53,81 91.5 <.001** 
TMT - B 16,66 53,31 130.5 <.001** 
ML 52,50 45,86 528.0 .368 
Performance 
Total 
82,31 39,66 51.0 <.001** 
* p ≤ 0.05 ** p ≤ 0.01 











SD M SD M SD F p 
DD 10,52 2,67 9,57 3,07 9,09 3,03 1,713 .187 
DI 5,58 2,31 4,26 2,20 4.96 2,44 2,150 .124 
FCRc 31,45 7,09 29,11 7,89 28,46 6,39 1,341 .268 
FCRm 19,65 6,58 15,54 8,19 13,61 7,13 4,936 .010* 
Cd 53,42 18,65 49,30 16,45 51,52 12,52 0,418 .660 
PC 7,10 3,76 6,04 2,95 5,91 2,94 1,073 .347 
StroopP 78,69 17,16 74,74 18,46 72,17 13,77 1,025 .364 
StroopC 63,35 12,91 58,96 12,32 59,39 11,03 1,095 .340 
StroopI 39,97 9,73 37,52 9,13 34,52 9,09 2,235 .114 
TMT-A 46,10 28.44 52,13 27,85 46,96 13,70 0,430 .652 
TMT-B 78,06 43,07 94,09 48,64 84,91 35,73 0,924 .402 
ML 13,10 5,18 11,52 4,43 11,35 4,04 1,194 .309 
Performance 
Total 
0,46 7,91 -3,53 8,12 -3,64 6,68 2,609 .080 









Tabela 5. Correlação de Spearman entre os índices de desenvolvimento cerebral 
fetal e parâmetros neonatais e os resultados do grupo CC nas diferentes provas 
neuropsicológicas.  
 














  rho p rho p rho p rho p rho p 
DD -.044 .735 .216 .092 .339* .011 .064 .610 .078 .523 
DI -.179 .163 -.037 .772 .260 .055 -.044 .729 .067 .583 
FCRc -.172 .182 .147 .253 .297* .027 .207 .095 .254* .035 
FCRm -.228 .075 .166 .197 .091 .507 .040 .752 .100 .414 
Cd -.196 .126 -.066 .611 -.017 .901 .095 .448 .060 .626 
PC -.182 .157 -.059 .648 .264 .051 .128 .306 .340** .004 
StroopP .052 .688 .245 .055 .231 .089 .185 .136 .089 .467 
StroopC -.015 .906 .158 .220 .256 .059 .115 .356 .144 .239 
StroopI .164 .203 .207 .107 .283* .036 .122 .329 .076 .535 
TMT-A .062 .631 -.014 .915 -.321* .017 -.015 .908 -.147 .227 
TMT-B .081 .531 .024 .853 -.127 .355 -.012 .926 -.148 .224 
ML -.211 .099 .035 .789 .263 .052 .197 .114 .177 .146 
Performance 
Total 
-.181 .160 .121 .351 .361** .007 .130 .298 .232 .055 
Tabela 6. Correlação de Spearman entre os índices de desenvolvimento cerebral 















 rho p rho p rho p rho p rho p 
DD -.110 .578 .204 .298 .154 .454 .012 .952 .038 .846 
DI -.214 .274 -.108 .583 .149 .467 -.134 .498 -.172 .373 
FCRc -.092 .642 .077 .698 .145 .479 .309 .110 .236 .217 
FCRm -.260 .292 .177 .367 .178 .384 .056 .776 .126 .516 
Cd -.296 .127 -.013 .949 -.078 .704 .200 .307 .170 .378 
PC -.035 .860 .204 .297 .463* .017 .082 .677 .518** .004 
StroopP -.041 .835 .278 .152 .108 .601 .428* .023 -.289 .128 
StroopC -.046 .815 .139 .480 .221 .277 .269 .166 .232 .226 
StroopI .282 .146 .209 .285 .186 .363 .249 .201 .178 .355 
TMT - A -.038 .849 -.165 .403 -.397* .045 -.335 .082 -.333 .077 
TMT - B -.003 .987 -.051 .798 .020 .923 .008 .968 -.197 .305 
ML -.120 .543 .013 .949 .305 .130 .115 .560 .333 .078 
* p ≤ 0.05 ** p ≤ 0.01 
 
Tabela 7. Correlação de Spearman entre os índices de desenvolvimento cerebral 















 rho p rho p rho p rho p rho p 
DD .127 .627 .406 .106 .506 .065 .141 .564 .317 .162 
DI .012 .963 .221 .393 .478 .084 .166 .496 .366 .102 
FCRc -.297 .247 .210 .418 .358 .209 .371 .118 .458* .037 
FCRm -.343 .177 .073 .782 .067 .820 -.024 .922 .160 .490 
Cd -.003 .992 .101 .700 .245 .399 .015 .952 .077 .741 
PC -.270 .295 -.223 .389 .300 .298 .143 .559 .149 .519 
StroopP .323 .206 .523* .031 .316 .272 .184 .450 .016 .946 
StroopC .267 .301 .559* .020 .357 .211 .212 .384 .256 .263 
StroopI .178 .495 .378 .134 .507 .064 .087 .724 .150 .516 
TMT - A .023 .929 -.103 .694 -.129 .659 .216 .374 -.030 .899 
TMT - B -.102 .696 -.171 .512 -.374 .187 .007 .977 -.120 .604 
ML -.280 .276 .030 .909 .286 .321 .096 .694 .004 .985 
* p ≤ 0.05 ** p ≤ 0.01 
 
Tabela 8. Correlação de Spearman entre os índices de desenvolvimento cerebral 















 rho p rho p rho p rho p rho p 
DD -.130 .618 -.204 .432 .366 .180 .059 .812 -.239 .324 
DI -.430 .085 -.506* .038 .208 .457 -.079 .748 -.016 .948 
FCRc -.181 .487 -.164 .529 .290 .294 -.322 .179 -.144 .556 
FCRm -226 .383 -.329 .197 -.261 .347 -.169 .490 -.293 .223 
Cd -.448 .072 -.502* .040 -.241 .387 -.023 .924 -.141 .564 
PC -.261 .312 -.103 .693 -.146 .604 .017 .944 .229 .346 
StroopP -.182 .485 -.223 .389 .432 .108 -.252 .298 -.203 .405 
StroopC -.298 .246 -.339 .184 .184 .511 -.379 .110 -.310 .197 
StroopI -.082 .755 -.265 .304 .145 .605 -.243 .317 -.395 .094 
TMT - A .273 .290 .446 .073 -.273 .326 .291 .226 .242 .318 
TMT - B .565* .018 .584* .014 -.002 .995 .210 .389 .120 .624 
ML -.206 .424 -.133 .610 -.085 .764 .423 .071 .094 .701 
* p ≤ 0.05 ** p ≤ 0.01 
 
Tabela 9. Regressão linear: cianose e perímetro cefálico são os principais preditores 
do desempenho cognitivo em adolescentes com cardiopatias congénitas. 
Modelo R R
2 
















    .256 1,979 .053 

























 Termo de Consentimento Informado 
 
 
Eu, ________________________________________________________, depois de ter 
sido integralmente informado dos objetivos e âmbito do Projeto de Investigação 
intitulado " Impacto do Desenvolvimento Fetal no Funcionamento neurocognitivo em 
Adolescentes com Cardiopatias Congénitas Cianóticas e Acianóticas", declaro que 
aceito participar neste estudo. 
Além de ter sido garantida a confidencialidade dos dados recolhidos, fui também 
informado de que, em caso de não aceitar participar neste projeto, não ocorrerão 


































Ficha de Identificação 
Ficha de Identificação 
 
Código: ____         Data: ____ 
Nome: ________________________________________________________ 
Morada: _______________________________________________________ 
Localidade:  _______________ Telefone: ___________ Telemóvel: _______ 
Nome da mãe: __________________________________________________ 
Nome do pai: ___________________________________________________ 
Idade: ______ Data de Nascimento: ___/___/___ Nacionalidade: __________ 
Estado Civil: _________ Agregado Familiar: __________________________ 
Fratria: ___________ Sexos: __ Masculino __ Feminino  Idades: __________ 




Idade de Diagnóstico: ___________ 
Terapêutica Médica: ____________ 
Intervenção Cirúrgica: __ Sim  __ Não          Tipo de intervenção: __________ 
Perímetro Cefálico: _____________ 
Comprimento: _________________ 
Peso: ________________________ 
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Aims: to assess the quality of life (QOL), psychiatric morbidity and the psychosocial 
adjustment (PSA) of adolescents and young adults with Congenital Heart Disease 
(CHD) and determine which variables play a role in buffering stress and promoting 
resilience and which ones have a detrimental effect; to investigate the situation on 
school performance and failures, social and family support, physical limitations and 
body image of these patients. Methods: The study enrolled 137 CHD patients (79 
males), 12 to 26 years (M: 17.60 ± 3.450 years). The participants were interviewed 
regarding social support, family educational style, self-image, demographic information 
and physical limitations. They responded to questions in a standardized psychiatric 
interview (SADS-L) and completed self-reports questionnaires for assessment of QOL 
(WHOQOL-BREF) and PSA (YSR/ASR). Results: We found a 19.7% lifetime 
prevalence of psychopathology in our participants (27.6% in females and 13.9% in 
males). 48% had retentions in school (M=1.61 year + 0.82). The perception of QOL of 
CHD patients is better compared to the Portuguese Population in the Social 
Relationships and Environmental Dimensions. However, is worse in complex forms of 
CHD than in moderate to mild ones, in cyanotic versus acyanotic patients, in moderate-
to-severe versus mild residual lesions, in patients submitted versus those not submitted 
to surgery, in patients with versus without physical limitations, and patients  who have 
versus those who haven't need for medication. Social Support is very important in 
improving QOL of patients in all dimensions as well as academic performance.  
Conclusions: Female patients and patients with poor academic performance and poor 




Congenital heart disease (CHD) is defined as a malformation of the heart or the large 
blood vessels that develops during the fetal period. Clinically, it is classified as cyanotic 
or acyanotic based on the gradient of oxygen saturation in the blood 
1,2
.   
Recent progress in early diagnosis and treatment has increased the life expectancy of 
patients with CHD. Today, 90% of newborns diagnosed with CHD live to adulthood, 
and this population is increasing at the rate of approximately 5% per year 
3-6
. Advances 
in pediatric cardiac care have resulted in an increasing number of adults with CHD 
being followed up in tertiary care centers, fact that is generating interest in adult CHD 
on the standpoint of a new subspecialty of cardiology. The prevalence of CHD is 




As survival rates improve, psychosocial issues have emerged as a critical research area. 
A prominent clinical concern is patient perception of quality of life (QOL)
8
, 
psychosocial adjustment and psychiatric morbidity. 
Evaluation of health-related quality of life is becoming increasingly important for 
patients with CHD in view of the increase of patients who survive. Quality of life is 
defined as a multi-dimensional construct integrating physical, emotional, and social 
well-being and functioning as perceived by the individual. 
9,10
 
To date, studies of QOL in CHD patients have reported contradictory findings. Some 
studies reported that poorer QOL is related to cardiac instability 
11
, disease severity 
12,13
, 
motor functioning and autonomy
14
, although no differences were found for the variables 
of gender, age or marital status 
11
. Some studies found poorer psychological well-being 
and QOL in CHD patients compared to healthy controls 
15,16
, while others claimed there 
was no difference between the two groups. Some researchers have reported that the 
congenital nature of the disease leads CHD patients to have better QOL than healthy 
people 
17,18
.   
Studies indicate that patients with CHD have persistent cardiac defects, a poor quality of 
life and psychosocial adjustment problems 
19
. Moreover other studies indicate that 
individuals with CHD have a good psychosocial adaptation 
20
.   
In the case of psychosocial adjustment, parents and partners tend to report more 
behavior and emotional problems than the patient himself.
20-22
 Patients with CHD are 
considered to be at increased risk of psychological and emotional difficulties.
17,23 
Thus, 
is very important to understand which variables have a detrimental effect in 
psychosocial adjustment and well-being of patients and which ones increase resilience 
and ability to adapt. The importance of our research was that it systematically addressed 
the question of which demographic or clinical variables have an impact over quality of 
life, psychosocial adjustment, or psychiatric morbidity. 
 
Materials and methods 
Participants 
The study enrolled 137 CHD patients (79 males and 58 females) with a mean age: 17.60 
± 3.450 years (range:12-26 years old) who are followed in consultation in the Pediatric 
Cardiology or Adult Cardiology Departments of a tertiary hospital in Portugal. We 
excluded patients that had not achieved a basic educational level that enables to 
understand and complete the written questionnaires; we only included participants who 
had complete medical records. 
At the time of the study, two participants were married, one was divorced, and two were 
living in a marital union. All the other participants were single (132). Of the all 
participants, 20 were employed full- or part-time, 7 were unemployed, and all the others 
were students. 
With regard to educational level, one completed the 4 first years in school, twenty the 6 
first years, fifty-five the 9 first years, fifty-five completed the whole secondary 
education and six an university degree. 
Patients' clinical files were provided by the department of Cardiology or Pediatric 
Cardiology. For 71 individuals, the congenital cardiac malformation was cyanotic, and 
for 66 patients, it was acyanotic. According to clinical files, at the time of diagnosis, 38 
participants exhibited a severe form of CHD, 25 had a moderate form, and 74 had a 
mild form. As far as the residual lesions are concerned, 4 participants had severe 
residual lesions, 27 had moderate residual lesions, and 105 had mild residual lesions. 
The study also included the participation of 128 relatives. 
The diagnosis was determined during the neonatal period for 73 of the participants, 
before the first birthday for 31, between the ages of 1 and 3 years for 5, between the 
ages of 3 and 6 years for 8 of the participants, between the ages of 6 and 12 years for 11 
of the participants, and between the ages of 12 and 18 years for 9 of the participants. In 
several participants, the main CHD was combined with other heart diseases.  
Individuals with associated extra cardiac malformations or chromosomopathies were 
excluded from the study.  Participants exhibited the following distribution of  
pathologies: Transposition of the Great Arteries (20 individuals; 4 also had Ventricular  
Septal Defect, 1 had Aortic Stenosis, 1 had Pulmonary Stenosis, and 2 had Coarctation 
of the Aorta), Tetralogy of Fallot (30), Coarctation of the Aorta (13, besides those 2 
referred above), Ventricular Septal Defect (19, 1 also had Interrupted Aortic Arch, and  
another also had Mitral Insufficiency), Atrial Septal Defect (16 individuals; 1 had also  
Mitral Atresia and Pulmonary Hypertension), Atrioventricular Septal Defect (5), Aortic  
Stenosis (8), Pulmonary Stenosis (13), Single Ventricle (2 individuals; 1 of these 
individuals also had Pulmonary Atresia, and 1 had Pulmonary Stenosis), Patent Ductus  
Arteriosus (2), Double Outlet Right Ventricle (1), Ebstein Anomaly (3), and Pulmonary  
Atresia (5).  For participants who underwent surgery (103), the first surgery was 
performed during the neonatal period for 6, before the first birthday for 35, between the 
ages of 1 and 3 years for 19, between the ages of 3 and 6 years for 21, between the ages 
of 6 and 12 years for 11 of the participants, between the ages of 12 and 18 years for 10 
of the participants, and after of 18 years for 1 of the participants. 
One or more of the following psychiatric disorders had been diagnosed for 27 of the 
participants (19, 7%) before the interview: minor or major depressive syndrome (n=14), 
panic disorder (n=3), anxiety disorder (n=6), or manic syndrome (n=3), and 
cyclothymic personality (n=1). 
 
Assessment Instruments 
The subjects were interviewed on only one occasion. A complete clinical history and 
demographic information were collected in a questionnaire (e.g., diagnosis, severity and 
category of CHD, course of illness, surgeries, presence of residual lesions, and 
treatment with medication) and demographic information (e.g., marital status, 
educational level, and occupation). 
The participants also responded to a semi structured interview covering topics such as 
social support, family educational style, environment, self-image, functional limitations, 
educational background, and emotional adjustment. 
A standardized psychiatric interview (SADS-L) was administered to obtain a clinical 
diagnosis of any psychopathologic disorders that may have existed prior to the 
interview. The participants completed self-report questionnaires like WHOQOL-BREF 
for assessment of their QOL, and YSR or ASR for assessment of psychosocial 
adjustment (PSA). One of their caregivers completed an observational version of the 
same questionnaires (CBCL or ABCL, according to the age of patients). 
The WHOQOL-BREF is a self-report questionnaire that assesses subjective QOL in 
both healthy individuals and those with wide range of psychological and physical 
disorders. It is a 26-item Likert-type scale with ratings from 1 to 5. For almost all the 
scale items, higher scores reflect a higher QOL. However, for three items (questions 3, 
4, and 26), higher scores reflect a lower QOL. The first two questions of the instrument 
assess general QOL. The WHOQOL-BREF also assesses four dimensions of QOL: 
physical (questions 3, 4, 10, 15, 16, 17, and 18), psychological (questions 5, 6, 7, 11, 19, 
and 26), social (questions 20, 21, and 22), and environmental (questions 8, 9, 12, 13, 14, 
23, 24, and 25). 
YSR or ASR are self-report questionnaires that assess behavior problems of youth or 
adults in the last 6 months. It is 112-item Likert-type scale for youth (YSR) and 123–
item for adults (ASR) with ratings from 0 to 2. Items on the scale of youth are grouped 
into eight syndromes: Withdrawn, Somatic Complaints, Anxious/Depressed, Social 
Problems, Thought Problems, Attention Problems, Delinquent Behavior, and Aggressive 
Behavior. Items on the scale of adults are grouped into eight syndromes: 
Anxious/Depressed, Withdrawn, Somatic Complaints Thought Problems, Attention 
Problems, Aggressive Behavior, Rule-Breaking Behavior and Intrusive. 
 
Procedure 
Prospective participants were contacted before or after scheduled hospital appointments. 
The subjects were asked to participate after being fully informed of the objectives and 
procedures of the investigation. Those who agreed completed an informed consent form 
approved by the hospital’s ethical committee, which followed international conventions 
guaranteeing the rights of the patients. 
 
Design 
All the assessment measures were obtained on a single occasion. Clinical data were 
collected retrospectively using each patient’s clinical record, with assistance from 
hospital medical staff. 
 
Methods of Statistical Analysis 
Statistical analyses of the data were performed using the IBM Social Package for the 
Social Sciences (SPSS), version 20.0 (SPSS, Chicago, IL, USA). The distribution of all 
the variables was tested. Differences for parametric variables were established using 
Student’s t-tests, and differences for nonparametric variables were established using 
Mann–Whitney U tests and Chi-square tests of association. 
 
Results 
We found a 19.7% lifetime prevalence of psychopathology (27.6% in females and 
13.9% in males). 
48% of our participants had retentions in school (M=1.61 year + 0.82). 
There were no significant differences in QOL for presence/ absence of psychiatric 
diagnosis. However, QOL (Physical dimension: t= -2.926; p= 0.004) is worse in 
complex than in moderate-to-mild forms of the CHD as well as PSA, with patients 
exhibiting more internalization problems (u= 1310.000; p= 0.019) and more delinquent 
behavior (u= 1435.000, p= 0.042). Cyanotic patients, compared to acyanotic, have 
worse QOL on Physical (t= -2.575; p= 0.011) and Environmental (t= -3.149; p= 0.002) 
dimensions. 
Patients with moderate-to-severe residual lesions had worse perception on QOL than 
those with mild lesions, in the Physical dimension (t= -2.379; p= 0.019). These patients 
also show worse psychosocial adjustment, with more somatic complaints (u=525.500; 
p=0.039) and internalization problems (u=1217.000; p=0.035). 
Female patients refer more somatic complaints (u= 590.500; p= 0.007), more feelings of 
anxiety/ depression (u= 1566.000; p= 0.002), thought problems (u= 1578.500; p= 
0.001), aggressive behaviors (u= 1552.500; p= 0.001), internalization (u= 1296.000; p= 
0.000), and externalization (u= 1724.500; p= 0.049) problems in PSA scales. They also 
show worse QOL on Environmental dimension (t= 2.856; p= 0.05). 
The perception of QOL of CHD patients is better than in the Portuguese population as a 
whole in the Social Relationships and Environmental Dimensions, but not in the 
Physical Dimension. (Table 1) 
 
Table 1. Comparison between reference values and the values presented by the 







Physical M = 77.49            
DP = 12.27 
M = 66.69               
DP = 13.72 
-15.053 0.000 
 
Psychological M = 72.38 
DP = 13.50 
 M = 70.72                    




M = 70.42           
DP =14.54 
M = 75.20 
SD = 15.33 
3.540 0.001 
Environmental M = 64.89 
DP = 12.24 
M = 73.16 
SD = 13.14 
5.768 0.000 
General QOL M = 71.51            
DP = 13.30 
M = 73.83                
DP = 14.14 
1.234 0.107 
 
* For the Portuguese population as a whole 
 
Patients submitted to surgery (N=103) have worse perception of QOL, on the Physical 
(t= -3.202; p= 0.002), Psychological (t= -2.949; p= 0.004) Social Relationships (t= -
1.982; p= 0.049) and General Dimensions (u= 1269.000; p= 0.011) than those who were 
not operated (N=34).  Those submitted to more than two surgeries have also worse 
QOL, on Physical (t= -3.541; p= 0.024) Psychological (t= -2.145; p= 0.014) and general 
dimensions (u= 1659.500; p=0.004). In the assessment of Psychosocial Adjustment, 
they also show higher scores in withdrawn behaviors (u=1335.000; p=0.036), attention 
problems (u= 1262.000; p= 0.014) and externalization problems (u=1209.500; p= 
0.032). 
Patients with physical limitations (N= 44) showed a worse perception in Physical (t= -
3.123; p= 0.002), Psychological (t= -2.902; p= 0.004) and General QOL (u= 1532.000; 
p= 0.012) than those without PL (N= 93). They also have more withdrawn behavior 
(u=1454.000; p=0.006), anxiety/ depression (u=1499.500; p=0.011), delinquent 
behavior (u=1586.500; p=0.032) and internalization problems (u=1435.000; p=0.016). 
Patients with need for medication show worse QOL only in Physical dimension (t= -
2.252; p= 0.026) than those who are not medicated. 
Participants with better academic performance showed better QOL on Psychological (t= 
2.454; p= 0.015), Environmental (t= 2.577; p= 0.011) and General dimensions (u= 
1351.000; p= 0.015). Those with poor academic performance show worse psychosocial 
adjustment, with more feelings of anxiety and depression (u=1312.500; p=0.013), more 
attention problems (u=1171.500; p=0.001) and more externalization problems 
(u=1190.500; p= 0.005). 
Social Support is very important in improving QOL of patients in all dimensions. (Table 
2) Participants with poorer Social Support show also more withdrawn behavior (u= 
781.000; p= 0.000) and more social problems (u= 1011.000; p= 0.010) in PSA scales. 
Table 2. Comparison of the perception of social support (more or less social support)  in 
the various dimensions of quality of life. 
 
 More SS             
(N = 109) 
Less SS   
(N = 28) 
 
Dimensions M SD M SD t p 
Physical 26.08 3.818 24.07 3.558 2.520 0.013 
 




12.28 1.689 11.00 2.073 3.420 0.001 
 
 
Environmental 31.89 4.038 29.54 4.293 2.703 0.008 
 
 M SD M SD U p 






Individuals with CHD has been increasing in adult population all over the world due to 
advances in early diagnosis and medical and surgical treatment 
7
. Thus, the contribution 
of our research is important because we tested the effects of different demographic, 
clinical, and psychosocial variables on the perception of QOL, on psychosocial 
adjustment and psychiatric morbidity of CHD patients. To our knowledge, no other 
published study before studied so many variables as we had. 
To determine the extent to which these factors enhanced resilience or had a detrimental 
effect on individuals with CHD, we analyzed factors such as severity of illness, number 
of surgeries, presence of residual lesions, presence of cyanosis, occurrence of 
psychopathologic disorders, education and academic achievement, size and functioning 
of the social support network, and physical abilities and limitations. 
An intriguing finding of our study, however confirming data from other authors, is that 
CHD patients in the whole perceive in a better way their quality of life than the healthy 
population. 
17, 18 
That fact may be explained by the presence of some buffer variables, 
like family environment and cohesion, and social support. 
However, when we look the different subgroups, we find that patients submitted to 
surgery show a worse perception on their quality of life than the whole group. These 
facts, more expected, may be explained by the daily life restrictions and residual side 
effects that limit physical performance and activity, and by the feeling of life threat and 
fragility, occurring in surgeries. 
The comparison between cyanotic and acyanotic patients and those with moderate-to-
severe or those with mild residual injuries show also a worse perception on quality of 
life. Complex CHD show a worse psychosocial adjustment and quality of life than 
moderate-to-mild forms of disease, as well. 
In the literature the predictors of behavioral and emotional problems pointed are being 
female, having low exercise capacity, having restrictions imposed by physicians, the 
type of heart lesion, underwent surgery in early infancy, and a greater number of heart 
operations.
25-26 
In this study for Psychosocial Adjustment, we found that being female, 
have poor academic performance, have a complex form of CHD, have moderate-to-
severe residual lesions, are submitted to surgery and have physical limitations are a 
predictors. 
The results of this study suggest that was 19.7% lifetime prevalence of 
psychopathology. In the others studies, the younger patients showed more 
psychopathology than the older patients.
23,24
 On the other hand, studies on the level of 
psychopathology in congenital heart disease adults show conflicting results, varying 
from elevated levels of psychopathology to levels similar to those of peers.
28, 29
   
In Portugal, there are no final data on psychiatric morbidity nationwide, although some 
estimation on the prevalence of psychiatric disorders in the general population could be 
made on the basis of partial studies.
30
 Referring to those findings, we may say that CHD 
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Impact of fetal development on neurocognitive performance of adolescents with 
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Purpose: Our aim was to evaluate the neurocognitive performance in adolescents with 
CHD and to determine whether parameters of fetal development evaluated in neonates, 
such as head circumference, length, weight and Apgar scores, are somehow related to 
their neurocognitive performance.  
Methods: 77 CHD patients (43 males) aged from 13 to 18 years old (mean=15.04 ± 
1.86), 46 cyanotic (23 Tetralogy of Fallot, 23 Transposition of the Great Arteries) and 
31 acyanotic (Ventricular Septal Defect) enrolled in this study. The control group 
included 16 healthy children (11 males) ages ranging from 13 and 18 (mean=15.69 ± 
1.44).  All assessment measures for CHD patients were once obtained in a tertiary 
hospital; the control group was evaluated in school. Demographic information and 
clinical history were collected. Neuropsychological assessment included Wechsler’s 
Digit Test, direct and reverse (WDD, WDR) and Symbol Search (WSS), Rey’s 
Complex Figure (RCF), BADS`s Key Searching Test (BKS), Color-Word Stroop Test 
(CWS), Trail Making Test (TMT) and Logical Memory Task (LMT).  
Results: CHD patients compared to control group showed lower scores in WDD 
(u=262.500; p<0,001) and WDR (u=166.500; p<0.001) versions, in RCF, copy 
(u=152.500; p<0,001) and memory (u=149.000; p<0.001), in WSS (u= 380.000; 
p=0.042), in BADS`s Key Searching Test (u= 160.500; p<0.001) in CWS, words 
(u=147.000; p<0.001), colors (u=225.000; p<0.001) and interference (u=133,500; 
p<0.001) in TMT, A (u=91.500; p<0.001) and B (u=130.500; p<0.001) and in Total 
Performance (u=51,000; p<0.001). Cyanotic patients, when compared to acyanotic, 
showed lower scores in all neuropsychological tasks, although the only differences that 
were significant were in  RCF, copy (u=935.500; p=0.020), memory (u=989.000; 
p=0.004) in CWS, interference (u=903,000; p=0.048). Several correlations were 
apparent between fetal/ neonatal parameters and neuropsychological abilities in each 
type of CHD. However, head circumference at birth stands as a main correlation with 
cognitive development later on in all kinds of CHD (WDD: rho=0.339, p=0.011; RCF, 
copy: rho=0.297, p=0.027; CWS, interference: rho=0.283, p=0.036; TMT A: rho=-
0.321, p=0.017; LMT: rho=-0.263, p=0.052).  
Conclusion: Adolescents with CHD have worse neuropsychological performance than 
the control group, mainly the cyanotic patients. Fetal circulation seems to have impact 
on cerebral and somatic growth, predicting cognitive impairment in adolescents with 
CHD. 
 
 
